Microdosing &
Mom Brain
What the science says about your changed brain, your mental load, and what we're learning about psilocybin's role.
In 2017, researchers at the Autonomous University of Barcelona scanned women's brains before pregnancy, after pregnancy, and two years later. They found measurable, long-lasting reductions in gray matter, so consistent that a computer could identify which women had been pregnant from a brain scan alone.
The reductions are not damage. They are specialization. The regions that shrink are the ones that help us read what other people are thinking and feeling. The brain is pruning itself to become more sensitive to a baby's needs. (Hoekzema, Nature Neuroscience, 2017)
A 2022 follow-up confirmed these changes affect cortical thickness, white matter, and the brain's resting activity, and many persist for years. (Hoekzema, Nature Communications, 2022) Recent research also documents real cognitive shifts postpartum, especially in attention, memory, and executive function. (Orchard, 2023)
Psilocybin is the active compound in psilocybin mushrooms. At a microdose (about one-tenth of a perceptible dose), there are no visual effects, no altered consciousness, no impairment. Below are the four things researchers have observed microdosing doing in the brain, and what each one may help with.
- Snapping at your kids. More space between feeling triggered and reacting.
- Low-grade morning dread. The receptor that sets your baseline gets gentler support.
- Feeling stuck in the same emotional rut. Easier to step out of a thought loop.
- Forgetting words mid-sentence. Recall pathways that thinned postpartum can rebuild.
- Feeling stuck in baby-mode. Non-mom parts of you become easier to access.
- Reacting the same way every time. New patterns form on top of the old reactive ones.
- 2am mental load spiral. The to-do list voice quiets enough to sleep.
- Mom-guilt loops. The same network drives self-criticism. When it quiets, the loops loosen.
- Never being able to put work down. Less mental noise means your brain stops working when you do.
- Being in the room but not really there. Less inner narrator means more presence.
- Don't expect day-three magic. Track for at least 30 days before you decide.
- Keep a simple log. The changes are subtle in real time, obvious in hindsight.
If pregnancy and breastfeeding are behind you, here is the honest framing on what microdosing can and cannot be.
Motherhood, especially the early years, is one of the hardest neurological and emotional transitions a human goes through. Your brain has reorganized. Your sleep is fractured. The mental load is constant. The version of you from before is not coming back, and the version you are becoming is still loading.
For the right person at the right time, microdosing can be a meaningful support through that transition. Not a fix for it. A support through it. The mothers who tell us it changed something for them tend to describe the same handful of things: more space before reacting, less noise at night, a sense of access to themselves again. None of it is dramatic. All of it adds up.
- Hoekzema E, et al. Pregnancy leads to long-lasting changes in human brain structure. Nature Neuroscience, 2017. nature.com/articles/nn.4458
- Hoekzema E, et al. Mapping the effects of pregnancy on resting state brain activity, white matter microstructure, neural metabolite concentrations and grey matter architecture. Nature Communications, 2022. nature.com/articles/s41467-022-33884-8
- Orchard ER, et al. Cognition in the postpartum: A systematic review and meta-analysis. 2023. pubmed.ncbi.nlm.nih.gov/37247705
- Vollenweider FX, et al. Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action. NeuroReport, 1998. pubmed.ncbi.nlm.nih.gov/9498561
- Ly C, et al. Psychedelics promote structural and functional neural plasticity. Cell Reports, 2018. cell.com/cell-reports/fulltext/S2211-1247(18)30755-1
- Carhart-Harris RL, et al. Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin. PNAS, 2012. pnas.org/doi/10.1073/pnas.1119598109
- Rootman JM, et al. Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers. Scientific Reports, 2021. nature.com/articles/s41598-021-01811-4
- Szigeti B, et al. Self-blinding citizen science to explore psychedelic microdosing. eLife, 2021. elifesciences.org/articles/62878
- Anderson T, et al. Psychedelic microdosing benefits and challenges: an empirical codebook. Harm Reduction Journal, 2019. harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-019-0308-4
- Prochazkova L, et al. Exploring the effect of microdosing psychedelics on creativity in an open-label natural setting. Psychopharmacology, 2018. link.springer.com/article/10.1007/s00213-018-5049-7